The tyrosine kinase inhibitor ZD6474 inhibits tumour growth in an intracerebral rat glioma model

Malignant glioma is characterised by extensive neovascularisation, principally influenced by vascular endothelial growth factor (VEGF). ZD6474 is a potent inhibitor of VEGF-R2 tyrosine kinase activity, but with additional inhibitory effects on other growth factors. In this study, we have investigate...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandström, M, Johansson, M, Andersson, U, Bergh, A, Bergenheim, A T, Henriksson, R
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Experimental Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747688/
https://www.ncbi.nlm.nih.gov/pubmed/15305185
http://dx.doi.org/10.1038/sj.bjc.6602108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747688/
https://www.ncbi.nlm.nih.gov/pubmed/15305185
http://dx.doi.org/10.1038/sj.bjc.6602108

Ejemplares similares